BEIJING – The Chinese unit of medical device maker Medtronic has been fined $17 million by anti-monopoly regulators in the latest effort by Beijing to force down what it sees as unreasonably high prices.
The Cabinet’s planning agency said Wednesday the company, which supplies cardiovascular, restorative, and diabetes-related medical devices, improperly suppressed competition through agreements with distributors that set minimum prices.
Chinese regulators have imposed similar penalties on foreign automakers, milk suppliers and other companies. Setting minimum retail prices is a common tactic in other markets but lawyers say Beijing appears to see them as a barrier to competition.
Wednesday’s government statement said minimum price agreements for medical devices hurt patients.
Local journalism is essential.
Give directly to The Spokesman-Review's Northwest Passages community forums series -- which helps to offset the costs of several reporter and editor positions at the newspaper -- by using the easy options below. Gifts processed in this system are not tax deductible, but are predominately used to help meet the local financial requirements needed to receive national matching-grant funds.
Subscribe to the Coronavirus newsletter
Get the day’s latest Coronavirus news delivered to your inbox by subscribing to our newsletter.